Comparative Metabolic Flux Profiling of Melanoma Cell Lines

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197

Cluster analysis and display of genome-wide expression patterns

Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905

On Respiratory Impairment in Cancer Cells

Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472

Otto Warburg's contributions to current concepts of cancer metabolism

Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427

Java Treeview—extensible visualization of microarray data

Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267

GeneCards Version 3: the human gene integrator

Safran, M., Dalah, I., Alexander, J., Rosen, N., Stein, T. I., Shmoish, M., Nativ, N., Bahir, I., Doniger, T., Krug, H., et al. (2010) · Database · doi:10.1093/database/baq020 · Cited by 2,134

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020

Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition

Sharma, R., Smalley, I., Spence, P., Sondak, V. K., Smalley, K. S. M., & Koomen, J. M. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00613 · Cited by 21

Novel Functions of CD147 in the Mitochondria Exacerbates Melanoma Metastasis

Lu, L., Zhang, J., Gan, P., Wu, L., Zhang, X., Peng, C., Zhou, J., Chen, X., & Su, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.52043 · Cited by 21

Amino Acid Signature in Human Melanoma Cell Lines from Different Disease Stages

Wasinger, C., Hofer, A., Oliver Spadiut, A., & HOHENEGGER, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24709-0 · Cited by 22

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications

Indini, A., Grossi, F., Mandalà, M., Taverna, D., & Audrito, V. (2021) · Biomedicines · doi:10.3390/biomedicines9060607 · Cited by 20

TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism

Ariano, C., Costanza, F., Akman, M., Riganti, C., Corà, D., Casanova, E., Astanina, E., Comunanza, V., Bussolino, F., & Doronzo, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05828-7 · Cited by 19

IL-6-Driven Autocrine Lactate Promotes Immune Escape of Uveal Melanoma

Gong, C., Yang, M., Long, H., Liu, X., Xu, Q., Qiao, L., Dong, H., Liu, Y., & Li, S. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.3.37 · Cited by 19

Metabolic reprogramming in cancer: mechanistic insights from Drosophila

Wong, K. K. L., & Verheyen, E. M. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048934 · Cited by 20

Upregulation of glycolysis and oxidative phosphorylation in benzo[β]pyrene and arsenic-induced rat lung epithelial transformed cells

Chen, H., Lee, L.-S., Li, G., Tsao, S., & Chiu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9814 · Cited by 19

Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma

Abildgaard, C., Rizza, S., Christiansen, H., Schmidt, S., Dahl, C., Abdul-Al, A., Christensen, A., Filomeni, G., & Guldberg, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-83796-8 · Cited by 18

Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Loftus, A. W., Zarei, M., Kakish, H. H., Hajihassani, O., Hue, J. J., Boutros, C., Graor, H. J., Nakazzi, F., Bahlibi, T., Winter, J. M., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102795 · Cited by 20

Chemical approaches to study metabolic networks

Medina-Cleghorn, D. A., & Nomura, D. K. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1201-0 · Cited by 17

Metabolic phenotyping of CHO cells varying in cellular biomass accumulation and maintenance during fed‐batch culture

Fernandez‐Martell, A., Johari, Y. B., & James, D. C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26485 · Cited by 17

Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma

Coazzoli, M., Napoli, A., Roux-Biejat, P., Palma, C. D., Moscheni, C., Catalani, E., Zecchini, S., Conte, V., Giovarelli, M., Caccia, S., et al. (2020) · Cells · doi:10.3390/cells9040848 · Cited by 17

Computational models of melanoma

Albrecht, M., Lucarelli, P., Kulms, D., & Sauter, T. (2020) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-020-00126-7 · Cited by 17

Cytotoxic mechanisms of panduratin A on A375 melanoma cells: A quantitative and temporal proteomics analysis

Lai, S.-L., Wong, P., Lim, T. K., Lin, Q., & Mustafa, M. R. (2015) · PROTEOMICS · doi:10.1002/pmic.201400039 · Cited by 17

WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis

Zhang, R.-S., Li, Z., Liu, J., Deng, Y., & Jiang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976117 · Cited by 20

Heterozygous P32/C1QBP/HABP1 Polymorphism rs56014026 Reduces Mitochondrial Oxidative Phosphorylation and Is Expressed in Low-grade Colorectal Carcinomas

Raschdorf, A., Sünderhauf, A., Skibbe, K., Ghebrehiwet, B., Peerschke, E. I. B., Sina, C., & Derer, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.631592 · Cited by 16

Mass Spectrometry-Based Method to Study Inhibitor-Induced Metabolic Redirection in the Central Metabolism of Cancer Cells

Araki, C., Okahashi, N., Maeda, K., Shimizu, H., & Matsuda, F. (2018) · Mass Spectrometry · doi:10.5702/massspectrometry.a0067 · Cited by 16

Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities

Bellazzo, A., Montico, B., Guerrieri, R., Colizzi, F., Steffan, A., Polesel, J., & Fratta, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02173-4 · Cited by 16

Mitochondrial bioenergetics and networks in melanoma: an update

Giannitti, G., Paganoni, A. J. J., Marchesi, S., Garavaglia, R., & Fontana, F. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02155-4 · Cited by 15

AC-93253 triggers the downregulation of melanoma progression markers and the inhibition of melanoma cell proliferation

Karwaciak, I., Gorzkiewicz, M., Ryba, K., Dastych, J., Pułaski, Ł., & Ratajewski, M. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.016 · Cited by 15

Right on TARGET: glutamine metabolism in cancer

Ratnikov, B. I., Jeon, Y. J., Smith, J. W., & Ronai, Z. A. (2015) · Oncoscience · doi:10.18632/oncoscience.205 · Cited by 15

Metabolic stress regulates ERK activity by controlling KSR‐RAF heterodimerization

Verlande, A., Krafčíková, M., Potěšil, D., Trantı́rek, L., Zdráhal, Z., Elkalaf, M., Trnka, J., Souček, K., Rauch, N., Rauch, J., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744524 · Cited by 16

HSF1: a mediator in metabolic alteration of hepatocellular carcinoma cells in cross-talking with tumor-associated macrophages.

Liu, H. T., Huang, D. A., Li, M. M., Liu, H. D., & Guo, K. (2019) · Europe PMC (PubMed Central) · Cited by 15

Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel

Kloepping, K. C., Kraus, A. S., Hedlund, D. K., Gnade, C. M., Wagner, B. A., McCormick, M. L., Fath, M. A., Seol, D., Lim, T. H., Buettner, G. R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244540 · Cited by 15

A preclinical model of cutaneous melanoma based on reconstructed human epidermis

Leikeim, A., Wußmann, M., Schmidt, F. F., Neto, N. G. B., Benz, F., Tiltmann, K., Junger, C., Monaghan, M. G., Schilling, B., & Groeber-Becker, F. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-19307-0 · Cited by 17

Mitochondrial substrates in cancer: Drivers or passengers?

Kruspig, B., Zhivotovsky, B., & Gogvadze, V. G. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.08.007 · Cited by 15

Metabolic Reprogramming in Melanoma: An Epigenetic Point of View

Giuliani, S., Accetta, C., Martino, S. D., Vitis, C. D., Messina, E., Pescarmona, E. O., Fanciulli, M., Ciliberto, G., Mancini, R., & Falcone, I. (2025) · Pharmaceuticals · doi:10.3390/ph18060853 · Cited by 15

Canonical Signaling Pathways in Melanoma

Sun, L., & Arbesman, J. (2021) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2021.05.002 · Cited by 14

Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients

Cheng, R., Yong, H., Xia, Y., Xie, Q., Gao, G., & Zhou, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.5769 · Cited by 14

Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer

Ara, H., Subedi, U., Sharma, P., Bhattarai, S., Sharma, S., Manikandan, S., Yu, X., Bhuiyan, M. S., Sun, H., Miriyala, S., et al. (2022) · Biomolecules · doi:10.3390/biom12121805 · Cited by 13

Germ Cell Proteins in Melanoma: Prognosis, Diagnosis, Treatment, and Theories on Expression

Rosa, A. M., Dabas, N., Byrnes, D. M., Eller, M. S., & Grichnik, J. M. (2012) · Journal of Skin Cancer · doi:10.1155/2012/621968 · Cited by 13

Analysis of Melanoma Cell Glutamine Metabolism by Stable Isotope Tracing and Gas Chromatography-Mass Spectrometry

Scott, D. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1205-7_7 · Cited by 13

Self-amplifying NRF2–EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer

Antonucci, L., Li, N., Durán, Á., Cobo, I., Nicoletti, C., Watari, K., Nandi, S. P., Zhu, F., Zhao, Y., Riahi, I., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01003-3 · Cited by 13

MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia

Copeland, C. A., Olenchock, B. A., Ziehr, D. R., McGarrity, S., Leahy, K., Young, J. D., Loscalzo, J., & Oldham, W. M. (2023) · eLife · doi:10.7554/elife.82597 · Cited by 12

Melanoma proteomics suggests functional differences related to mutational status

Trilla‐Fuertes, L., Gámez‐Pozo, A., Prado-Vázquez, G., Zapater‐Moros, A., Díaz‐Almirón, M., Fortes, C., Ferrer-Gómez, M., López‐Vacas, R., Blanco, V. P., Márquez‐Rodas, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43512-z · Cited by 12

Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study

Pópulo, H., Domingues, B., Sampaio, C., Lopes, J. M., & Soares, P. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s297831 · Cited by 11

The Role of Oxidative Stress in Melanoma Development, Progression and Treatment

de Melo, F. H. M., Molognoni, F., & Jasiulionis, M. G. (2013) · InTech eBooks · doi:10.5772/54937 · Cited by 13

Biofluorescence imaging-guided spatial metabolic tracing: In vivo tracking of metabolic activity in circulating tumor cell-mediated multi-organ metastases

Luan, H., Chen, S., Lian, J., Zhao, B., Xu, X., Chen, Y., Yang, Y., Jiang, Z., Qi, M., Liu, J., et al. (2024) · Talanta · doi:10.1016/j.talanta.2024.126696 · Cited by 10

Metabolic control analysis as a strategy to identify therapeutic targets, the case of cancer glycolysis

Marín‐Hernández, Á., & Saavedra, E. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.104986 · Cited by 10

Sex‐related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma

Iozzo, M., Comito, G., Ippolito, L., Sandrini, G., Pardella, E., Pranzini, E., Capone, M., Madonna, G., Ascierto, P. A., Chiarugi, P., et al. (2025) · FEBS Journal · doi:10.1111/febs.17423 · Cited by 11

Hypoxically cultured cells of oral squamous cell carcinoma increased their glucose metabolic activity under normoxic conditions

Shinohara, Y., Washio, J., Kobayashi, Y., Abiko, Y., Sasaki, K., & Takahashi, N. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254966 · Cited by 10

Real‐Time Monitoring of Cancer Cell Metabolism and Effects of an Anticancer Agent using 2D In‐Cell NMR Spectroscopy

Wen, H., An, Y. J., Xu, W. J., Kang, K. W., & Park, S. (2015) · Angewandte Chemie · doi:10.1002/ange.201410380 · Cited by 10

Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1

Kurashige, T., Shimamura, M. I., Hamada, K., Matsuse, M., Mitsutake, N., & Nagayama, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-27461-2 · Cited by 10

Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites

ZHOU, Y., Wen, F., Zhang, P., Tang, R., & Li, Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4522 · Cited by 10

Aneustat (OMN54) has aerobic glycolysis‐inhibitory activity and also immunomodulatory activity as indicated by a first‐generation PDX prostate cancer model

Qu, S., Xue, H., Dong, X., Lin, D., Wu, R. C., Nabavi, N., Collins, C. C., Gleave, M. E., Gout, P. W., & Wang, Y. Z. (2018) · International Journal of Cancer · doi:10.1002/ijc.31310 · Cited by 10

Exploiting Paradoxical Activation of Oncogenic MAPK Signaling by Targeting Mitochondria to Sensitize NRAS Mutant-Melanoma to Vemurafenib

do Prado-Souza, L. F. L., Ferraz, L. S., Tortelli, T. C., Ribeiro, C. A. J., Amaral, D. T., Arruda, D. C., de Oliveira, E. A., Chammas, R. J., Maria–Engler, S. S., & Rodrigues, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062675 · Cited by 9

Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells

Tang, T., Fang, D., Ji, Z., Zhong, Z., Zhou, B., Ye, L., Jiang, L., & Sun, X. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00887-6 · Cited by 9

Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis

Bowley, T. Y., Merkley, S. D., Lagutina, I. V., Ortiz, M. C., Lee, M., Tawfik, B., & Marchetti, D. (2023) · Cancers · doi:10.3390/cancers15215263 · Cited by 9

Advances in nanotechnology-related strategies against melanoma

Pinho, J. O., Lopes, J., Albino, M., Reis, C. P., Matias, M., & Gaspar, M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00009-7 · Cited by 9

The elevated D-2-hydroxyglutarate level found as a characteristic metabolic change of colon cancer in both in vitro and in vivo models

Atalay, E. B., & Kayalı, H. A. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.019 · Cited by 9

l-Proline uptake in Saccharomyces cerevisiae mitochondria can contribute to bioenergetics during nutrient stress as alternative mitochondrial fuel

Pallotta, M. L. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1415-0 · Cited by 9

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma

Farah, C., Mignion, L., & Jordan, B. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031725 · Cited by 8

Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act

Tiersma, J. F., Evers, B., Bakker, B. M., Reijngoud, D., de Bruyn, M., de Jong, S., & Jalving, M. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102802 · Cited by 8

Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma‐specific survival

Chen, K., Liu, H., Liu, Z., Bloomer, W., Amos, C. I., Lee, J. E., Li, X., Nan, H., & Wei, Q. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23100 · Cited by 8

Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts

Farah, C., Neveu, M.-A. C., Yelek, C., Bouzin, C., Gallez, B., Baurain, J., Mignion, L., & Jordan, B. F. (2022) · Biomedicines · doi:10.3390/biomedicines10030717 · Cited by 8

Metabolic Fluxes in Cancer Metabolism

Günther, U. L., Chong, M., Volpari, T., Koczula, K. M., Atkins, K. L., Bunce, C. M., & Khanim, F. L. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_14 · Cited by 8

Community-based network analyses reveal emerging connectivity patterns of protein-protein interactions in murine melanoma secretome

Francisquini, R., Berton, R., Soares, S. G., Gonçalves, D. S. P. O., Camacho, M. F., Andrade-Silva, D., Barcick, U., Serrano, S. M. T., Chammas, R. J., Nascimento, M. C. V., et al. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.104063 · Cited by 8

Fatty acid addiction in cancer: A high-fat diet directly promotes tumor growth through fatty acid oxidation

Kim, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189428 · Cited by 8

Metabolism at the core of melanoma: From bioenergetics to immune escape and beyond

Hsu, C., Ahmed, Y. K., mohammed, S., ALGhamdi, M. A., AL-Ghamdi, H. S., Mohammed, J. S., Jawad, M. A., & Alsaadi, S. B. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152413 · Cited by 7

A Metabolism-Driven Prognostic Model and PSMD14–SP1–GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma

Xie, J., Zhao, S., Wu, D., Ma, C., Yan, W., Zhang, P., Lu, Q., Wan, Z., Tang, Q., Li, L., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.08.044 · Cited by 7

Two octaves spanning photoacoustic microscopy

Nteroli, G., Dasa, M. K., Messa, G., Koutsikou, S., Bondu, M., Moselund, P. M., Markos, C., Bang, O., Podoleanu, A. G., & Bradu, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-14869-5 · Cited by 7

Small extracellular vesicle‐based human melanocyte and melanoma signature

Agüera‐Lorente, A., Alonso‐Pardavila, A., Larrinaga, M., Boyano, M. D., González, E., Falcón‐Pérez, J. M., Asumendi, A., & Apraiz, A. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13158 · Cited by 7

Biological Evaluation of a Rhodium(III) Bipyridylsulfonamide Complex: Effects on Mitochondrial Dynamics and Cytoskeletal Remodeling in Breast Cancer Cells

Audzeyenka, I., Piwkowska, A., Rogacka, D., Makowski, M., & Kowalik, M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02284 · Cited by 7

Preliminary Study: Proteomic Profiling Uncovers Potential Proteins for Biomonitoring Equine Melanocytic Neoplasm

Tesena, P., Kingkaw, A., Vongsangnak, W., Pitikarn, S., Phaonakrop, N., Roytrakul, S., & Kovitvadhi, A. (2021) · Animals · doi:10.3390/ani11071913 · Cited by 7

Is Mitochondrial Glutamine Fermentation a Missing Link in the Metabolic Theory of Cancer?

(2012) · Wiley eBooks · doi:10.1002/9781118310311.ch8 · Cited by 7

Metabolic Rebalancing of CR6 Interaction Factor 1-Deficient Mouse Embryonic Fibroblasts: A Mass Spectrometry-Based Metabolic Analysis

Tadi, S., Kim, S. J., Ryu, M. J., Park, T., Jeong, J., Kim, Y. H., Kweon, G. R., Shong, M., & Yim, Y. (2013) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2013.34.1.35 · Cited by 6

The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches

Abdullah, A., Kumbrink, J., Liokatis, P. G., Möck, A., Abdullah, A., Dewenter, I., & Obermeier, K. T. (2024) · Cancers · doi:10.3390/cancers17010048 · Cited by 5

Combination of niclosamide and quinacrine inactivates Akt/HK2/Cyclin D1 axis mediated by glucose deprivation towards the inhibition of melanoma cell proliferation

Li, S., Wang, D., Zheng, X., Li, Y., Ding, C., Wang, M., Ge, X., Jiang, J., Qiao, Y., & Wang, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114865 · Cited by 5

In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes

Gambichler, T., Harnischfeger, F., Skrygan, M., Majchrzak‐Stiller, B., Buchholz, M., Müller, T. H., & Braumann, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015336 · Cited by 5

Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells

Jéney, A., Hujber, Z., Szoboszlai, N., Fullár, A., Oláh, J., Pap, É., Márk, Á., Kriston, C., Kralovánszky, J., Kovalszky, I., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0281-x · Cited by 5

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells

Mesti, T., Bouchemal, N., Banissi, C., Triba, M. N., Marbeuf‐Gueye, C., Čemažar, M., Moyec, L. L., Carpentier, A. F., Savarin, P., & Ocvirk, J. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0046 · Cited by 5

Melanoma redox biology and the emergence of drug resistance

Featherston, T., Paumann-Page, M., & Hampton, M. B. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.06.004 · Cited by 4

Melanoma treatment in the era of nanotechnology and precision medicine

da Cruz, A. F., Colella, F., Grasso, G., Onesto, V., Forciniti, S., Ortiz, B. B., Carnevali, F., Siciliano, A. C., Bove, R., dos Santos, J. G., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03851-8 · Cited by 4

Targeted Metabolomics of Tissue and Plasma Identifies Biomarkers in Mice with NOTCH1-Dependent T-Cell Acute Lymphoblastic Leukemia

Tosello, V., Martino, L. D., & Piovan, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126543 · Cited by 4

NAD+ as a Target for Cancer Treatment

Helman, T. J., & Braidy, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_269-1 · Cited by 4

Energetics of Normal Cells and Cancer Cells

(2012) · Wiley eBooks · doi:10.1002/9781118310311.ch4 · Cited by 4

Targeting metabolic reprogramming to overcome immune tolerance in melanoma immunotherapy

Wang, Q., Shi, L., Shi, D., Tai, N., & Wang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597770 · Cited by 3

Cancer cachexia has many symptoms but only one cause: anoxia

Koltai, T. (2020) · F1000Research · doi:10.12688/f1000research.22624.1 · Cited by 3

Melanoma Metabolism

Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_28-2 · Cited by 3

The Transcriptional Landscape of BRAF Wild Type Metastatic Melanoma: A Pilot Study

Lastraioli, E., Ruffinatti, F. A., Bagni, G., Visentin, L., Costanzo, F. D., Munaron, L., & Arcangeli, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136898 · Cited by 3

Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation

Dian, A. L., Fabbri, L., Moya‐Plana, A., Claps, G., Ferreira, J. C., Labbé, C. M., Quidville, V., Martineau, S., Baïlle, D., Besse, L., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003364 · Cited by 3

Targeting Glycolysis with 2-Deoxy-D-Glucose and Lysosomal Integrity with L-Leucyl-L-Leucine Methyl Ester as Antimelanoma Strategy

Kosić, M., Bošnjak, M., Mandić, M., Vucicevic, L. M., Misirkic-Marjanovic, M., Poulsen, S. E., & Harhaji-Trajkovic, L. M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101312 · Cited by 2

Multiple Cutaneous and Uterine Leiomyomatosis

Makino, T. (2013) · InTech eBooks · doi:10.5772/53601 · Cited by 2

Melanoma Metabolism

Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_28 · Cited by 3

Mapping carbon utilization pathways in Histoplasma capsulatum through 13 C-metabolic flux analysis

Heckart, A., Cocuron, J., Ray, S. C., Matheny, G. F., Rappleye, C. A., & Alonso, A. P. (2025) · mSystems · doi:10.1128/msystems.00569-25 · Cited by 2

Prioritization and comprehensive analysis of genes associated with melanoma

Feng, C., Bai, M., Zhang, H., Zeng, A., & Zhang, W. (2019) · Oncology Letters · doi:10.3892/ol.2019.10284 · Cited by 2

Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics

Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_17 · Cited by 2

Is Respiration Normal in Cancer Cells?

(2012) · Wiley eBooks · doi:10.1002/9781118310311.ch7 · Cited by 2

HIF-1α drives distinct aspects of hypoxia-induced glucose metabolism in intestinal epithelial cells

Kierans, S. J., Kennedy, C., Turner, R., Flood, D., DeMichele, E., Wallace, M., & Taylor, C. T. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113193 · Cited by 1

Voltage-Dependent Anion Channels and Tubulin: Bioenergetic Controllers in Cancer Cells

Maldonado, E. N., DeHart, D. N., & Lemasters, J. J. (2017) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-55539-3_5 · Cited by 1

Inter-Relationship Between Melanoma Vemurafenib Tolerance Thresholds and Metabolic Pathway Choice

Nangia‐Makker, P., Ahrens, M., Purandare, N., Aras, S., Li, J., Gurdziel, K., Jang, H., Kim, S., & Shekhar, M. P. V. (2025) · Cells · doi:10.3390/cells14120923 · Cited by 1

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair

Aubé, F., Fontrodona, N., Guiguettaz, L., Vallin, E., Fabbri, L., Lapendry, A., Vagner, S., Ricci, E. P., & Auboeuf, D. (2024) · NAR Cancer · doi:10.1093/narcan/zcae019 · Cited by 2

G6PD Defect Inhibits the Growth of Nude Mice Xenograft Tumor in Human Melanoma Cells

Hu, T., Zhang, C., Qiong-Lin, T., & Zhu, Y. (2012) · Zhongguo shengwu huaxue yu fenzi shengwu xuebao

Residual breast cancer metabolic phenotype after docetaxel treatment

Volpari, T. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)

Using [U-13C6]-Glucose Tracer to Study Metabolic Changes in Oncogene-Induced Senescence Fibroblasts

Leonova, K. I., & Scott, D. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_11

A Role for Sirtuins in Maintaining Mammalian Lifespan and Healthspan

Giblin, W. (2017) · Deep Blue (University of Michigan)

Potential use of Aneustat for improvement of docetaxel-based therapy of advanced prostate cancer

Qu, S. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0357970

Metabolism: The Sweet Spot in Melanoma Precision Medicine?

Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_28-1

XILOGLUCANA DE SEMENTES DE Copaifera langsdorffii (COPAÍBA) E SEU COMPLEXO COM OXOVANÁDIO (IV/V): EFEITOS SOBRE CÉLULAS DE MELANOMA MURINO B16F10 IN VITRO

Noleto, R., & Martinez, R. (2012)

Abstract 69: Functional metabolomic profiling of human melanocyte and melanoma cells during hypoxic adaptation

Richardson, A. D., Scott, D. A., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-69 · Cited by 1

Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma

Filipp, F. V., Ratnikov, B. I., Ingeniis, J. D., Smith, J. W., Osterman, A. L., & Scott, D. A. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12000 · Cited by 115

Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy

Kakhki, N. R., Hegedűs, Z., Tóvári, J., Mirzahosseini, A., Noszál, B., & Kraszni, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352639

1H NMR based metabolites analysis of murine melanoma cells and primary melanocytes

Yang, Y., Shen, S., & Huang, S. (2025) · Journal of Biology Agriculture and Healthcare · doi:10.7176/jbah/15-1-01

Modelling metabolic rewiring during melanoma progression using flux balance analysis

Metri, R., Saxena, S., Mishra, M., & Chandra, N. R. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217638 · Cited by 1